TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Sedana Medical AB ( (SE:SEDANA) ) has issued an update.
Sedana Medical AB is set to release its interim report for the second quarter of 2025 on July 18, with a presentation scheduled for the same day. The report will be presented by the CEO, CFO, and CMO, providing insights into the company’s performance and strategy, which could impact its market positioning and stakeholder interests.
More about Sedana Medical AB
Sedana Medical AB is a medtech and pharmaceutical company specializing in inhaled sedation for mechanically ventilated patients in intensive care. The company offers the Sedaconda ACD medical device and Sedaconda (isoflurane) pharmaceutical, with direct sales in several European countries and partnerships in other global regions. Founded in 2005, Sedana Medical is listed on Nasdaq Stockholm and headquartered in Stockholm, Sweden.
Average Trading Volume: 375,874
Current Market Cap: SEK1.18B
Find detailed analytics on SEDANA stock on TipRanks’ Stock Analysis page.